Elekta Unity integrates the best of two worlds to create a new paradigm in cancer care
Uniting high-field 1.5T MR imaging, precision radiation therapy and intelligent software without compromise, Elekta Unity provides a tailored solution for the new field of magnetic resonance radiation therapy (MR/RT). The combination of technologies enables you to see and track the target, including changes in tumor position, shape and biology, and provides the real-time information you need to respond immediately—all while the patient is on the table.
“I believe radiotherapy guided by real-time MR imaging will replace conventional radiotherapy in the near future.”
Usher in a new standard of care with crystal-clear imaging during advanced radiation therapy
Deliver uncompromised, highly-targeted, precisely-dosed therapy through simultaneous MR imaging and radiation
Inspire confidence with an innovative platform, developed through extensive research and collaboration with global clinical and technology partners
“Reducing treatment volumes and sparing healthy tissue is a critical factor in improving the care and outcomes for patients treated with radiation therapy.”
Adapt to tumor position and shape in real time
Respond to tumor changes using superior insights through intelligent software
Ensure clinical intent provided through physician-driven protocol
“Bringing this technology into a clinical setting will be a profound step forward in a new era of personalised radiotherapy, with significant potential to improve patient outcomes.”
Expand your treatment offerings and opportunity to target hard-to-treat cancers
Go beyond anatomical imaging with precise biological radiation therapy
Unlock the future continuum of scan, plan and treat with intentional design and technological readiness
Shaista Hafeez, PhD: "Game-changing innovative technology"
William A. Hall, MD: "Personalized Radiotherapy"
Jan Lagendijk, PhD: "See what you treat"
Professor Uulke van der Heide, PhD: "A paradigm shift"
Elekta Unity has CE-mark and 510(k) clearance but not commercially available in all markets.